Program Director
Dr. Hiltke provides leadership and oversight to the Monoclonal Antibody Characterization program. She also works in developing other methods of antigen generation. Previously, Dr. Hiltke served as a senior scientist/project manager in assay development at both Wellstat Diagnostics and BioVeris Corporation, where she developed clinical assays for diagnostic markers using electrochemiluminescence platform and magnetic beads. Dr. Hiltke holds a Ph.D. degree (1999) in biology from the University of Buffalo.